Conclusion Actim PROM is a simple, cost-effective, reliable and fast in making an accurate PPROM diagnosis regardless of contaminating substances (e.g. blood, vaginal discharge, semen, urine and disinfectant solutions). Obstetricians and midwives were keen to use it and felt it was a valuable option where history was vague and clinical examination was inconclusive. Unnecessary interventions were avoided and correct treatment was started promptly when indicated. An enthusiastic approach to Actim PROM led to potential over-use even in cases with no indication. Optimal use, based on local guidelines, should be emphasised in order to benefit from avoiding inaccurate diagnosis. Periodic reaudits should be considered for maintaining the compliant clinical practice and improve antenatal management.
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Challenges in managing a pregnant woman with severe congenital cyanotic heart disease-a case report Jiayi, L; Kok, TL; Le, TJ; Loy, TE; Andy, TWK Singapore General Hospital, Singapore, Singapore Background Medical advances have increased survival of patients with congenital heart disease, resulting in >85% of them surviving into childbearing age. However, cardiac disease in pregnancy carries significant maternal and fetal risks, posing enormous challenge to obstetricians. In particular, cyanotic congenital heart disease is associated with increased maternal complications such as cardiac failure, arrhythmias, thromboembolic events and death. Associated fetal complications include small-for-gestational-age (SGA), miscarriage, prematurity and its associated morbidities. In this case report, we report a case of a pregnancy in a highly complex cyanotic congenital heart disease. Case Our patient is a 28-year-old primigravida with cyanotic congenital heart disease and a univentricular heart. Her 2D echography showed dextrocardia, tricuspid atresia, hypoplastic right ventricle and transposition of great arteries with atrial septal defect and ventricular septal defect. She underwent pulmonary artery banding at 6 weeks of life and bidirectional cavopulmonary connection with right pulmonary artery patch-plasty at 19 years. She was seen in our High Risk Clinic at 8 weeks of gestation of an unplanned pregnancy against medical advice and subsequently followed-up closely in our combined clinic with cardiologists. At 16 weeks of gestation, the patient was admitted for decreased effort tolerance from baseline, secondary to increased shunting across her septal defects. Multidisciplinary, e.g. obstetric, cardiology, anaesthesia, haematology, neonatology, cardiothoracic surgery meetings were held to co-manage the high-risk pregnancy. There were no fetal cardiac anomalies or evidence of fetal growth restriction shown on serial ultrasound scans. She underwent an elective caesarean section under general anaesthesia at 26 +5 weeks gestation in view of deteriorating cardiac function. A baby boy, 870 grams was delivered with Apgar scores of 4, 4, 6, 9 at 1, 5, 10 and 20 minutes. The baby was admitted to the Neonatal Intensive Care Unit in view of poor respiratory effort and developed multiple complications of extreme prematurity such as respiratory disorders, neurological and metabolic complications, subsequently discharged stable on Day 122 of life. The patient remained stable postoperatively and was discharged well on postoperative day 10. She had no deterioration in her cardiac function or functional class at her last cardiac review 4 months post delivery.
Conclusion There are few reported cases of successful pregnancies complicated by maternal cyanotic heart disease. These pregnancies require multidisciplinary care to ensure optimal management of the mother and fetus.
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A rare case of Staphylococcus lugdunensis endocarditis in pregnancy: a case report and review of literature Ashiq, S
Corniche Hospital, Abu Dhabi, United Arab Emirates
Background Infective endocarditis is very rare in pregnancy and related case reports are scarce. It is known to cause significant fetal and maternal morbidity and mortality. We present an interesting case of clinically significant bacteraemia (defined as positive blood cultures and systemic inflammatory response syndrome without an alternative explanation) in a pregnant woman.
Case This 28-year-old patient presented at 28 weeks and 4 days of gestation as feeling unwell with 5 days history of fever, chills and nausea. This was her second pregnancy and was a twin gestation complicated by gestational diabetes on treatment. Routine analysis revealed raised C-reactive protein (CRP) and mildly deranged liver enzymes. Her urine analysis and chest X-ray were normal. She was commenced on oral antibiotics and discharged home. She presented a couple of days later with persistent symptoms and was admitted for further evaluation. Her blood cultures revealed clusters of Gram-negative cocci, confirmed as Staphylococcus lugdunensis. Her liver functions remained stable but her CRP was rising. She was started on intravenous cefotaxime to which she did not respond. There was no identifiable source of infection. In view of her worsening condition, the Infectious medicine Consultant was involved who requested trans-oesophageal echocardiogram. This confirmed infective endocarditis as seen by a large vegetation on the tricuspid valve and moderate tricuspid regurgitation. Her antibiotics were changed to vancomycin and she had an emergency caesarean section for premature rupture of membranes. Her postoperative period was uneventful and she was transferred to the cardiac unit for surgical intervention. She had a valve repair and replacement and was advised to continue intravenous vancomycin for another 6 weeks.
Conclusion Staphylococcus lugdunensis causes a rare but destructive form of infective endocarditis that can involve structurally normal native valves. It is more aggressive than other coagulase-negative staphylococci and despite being sensitive to ª 2017 The Authors. BJOG An International Journal of Obstetrics and Gynaecology ª 2017 RCOG many antibiotics, it carries a high mortality rate compared with other staphylococci. Isolation of this organism should not be considered as a contaminant, instead there should be a low threshold for evaluation to rule out infective endocarditis. Hence it is imperative that this infection is familiar to physicians to avoid delay in diagnosis of a serious underlying pathology.
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Reducing caesarean section rates in women with one previous caesarean: an audit of current practice at Good Hope Hospital Self, A; Wilson, S
Heart of England Foundation Trust, West Midlands, UK
Introduction Where successful, a vaginal birth after caesarean (VBAC) has a lower overall morbidity than elective repeat caesarean section (ERCS). Good Hope Hospital's VBAC clinic was started in 2013 to improve VBAC rates. The RCOG states that all women with a previous caesarean should: receive information on the risks and benefits of VBAC; have continuous electronic fetal monitoring (cEFM) in labour; have Senior Obstetrician input regarding induction or augmentation; and the rates of VBAC and complications should be audited.
Methods The case notes of 108 women in Good Hope, who had a previous caesarean section delivery and delivered between 22 September 2015 and 31 December 15, were reviewed and audited. Data were obtained regarding the use of the VBAC clinic and current practice regarding antenatal care and delivery was compared to the RCOG's standards.
Results Only 39 women (36.1%) were referred to the VBAC clinic; 87% of women received or discussed information regarding the risk and benefits of VBAC but only 74.1% received written information. However of the women who attended the VBAC clinic, 100% received quality information. All hospital deliveries had cEFM. There was clear evidence of Consultant involvement in 70.6% of induced labours and 62.5% of augmented spontaneous labours. Forty-nine women (45.4%) requested a VBAC, 41 (83.7%) of whom had a trial of VBAC. A total of 58.5% (24/41) of women who had a trial of VBAC had a successful vaginal birth but this figure reduced to 48.4% (15/31) if they had not had a previous VBAC. If a woman had a spontaneous onset of labour she was more likely to have a successful vaginal birth than if labour was induced (58.5% versus 41.5%). Overall complication rates were slightly higher in women who attempted a VBAC compared with those who had a caesarean section (17.1% versus 15.1%) mostly attributed to more special care baby unit admissions (12.2% versus 7.5%).
Conclusion VBAC clinic referral to be offered to all women at the booking visit. Information leaflets about VBAC to be given to all women at booking visit. Staff will be reminded to document Senior Obstetrician involvement for any induction or augmentation of labour where the woman has previously had a caesarean delivery.
Rates of referral to the VBAC clinic to be re-audited.
JP204
Retrospective review of rescue cervical cerclage in a single tertiary centre Durai, S; Tang, TW; Tagore, S; Saffari, SE KK Womens' and Childrens' Hospital, Singapore, Singapore
Introduction Rescue cervical cerclage is defined as a cerclage performed on women of gestational age 16-26 weeks, who present with a dilated external cervical os with fetal membranes at or beyond the external os without uterine contractions. Current data suggest that rescue cerclage is associated with a longer latency period and, most often, with better pregnancy outcomes. In women with a dilated cervix, the membranes are exposed to vaginal flora without the mechanical protection of the closed cervix and its mucous plug. It is believed that this factor is associated with imminent delivery. Results Forty-five percent of admissions were undelivered and 25% were HIV-positive. Two-thirds of admissions had severe organ dysfunction requiring level 2 obstetric critical care, while one-third developed or had existing indications for level 3 obstetric critical care. The most common reasons for admission were pre-eclampsia, medical disorders, severe sepsis and massive haemorrhage. Intra-arterial lines were frequently used to guide resuscitation and administration of vasoactive drug infusions. Mask continuous positive airway pressure was used in preeclampsia patients with respiratory distress and pulmonary oedema, the intubation rate was only 12%. The overall maternal mortality was only 2.6%. The SAMM: mortality rate at the institution before the establishment of the OCCU, was one death in every five women admitted with severe morbidity, this decreased to one mortality in every 30 patients admitted with severe morbidity. Conclusion The study demonstrated that the OCCU provided effective care service which resulted in a reduction in mortality as well as very low mortality rate in women who suffered lifethreatening complications. The blueprint should be replicated in similar settings to decrease preventable mortality. Background Occurrence of Anti-Jk3 is very rare. This case describes a pregnant woman with unexpected antibodies for Jk3 of Kidd system. Case A 42-year-old, A blood group Rhesus-positive, gravida 3, para 1 woman was referred at 30 weeks of gestation with rising Jk3 antibody titre (1:128-1:256). Her first pregnancy had an antepartum haemorrhage and second pregnancy had a stillbirth due to hydrops fetalis. She was found positive for Anti-Jk3. Her first child's blood group is A Rhesus D-positive with Jk (a-b+). Middle cerebral artery peak systolic velocity Doppler screening was performed to identify the fetal anaemia and it was above the transfusion level at 30 weeks of gestation. Despite several compatibility tests, we were unable to find a suitable blood pack for fetal transfusion due to maternal antibody status. Currently in Sri Lanka there are no donors who are negative for both a and b Kidd antigens. This sorted to cross-match fetal blood with maternal blood as the only option. Cordocentesis confirmed fetal blood group A, Rh D-positive and severe fetal anaemia. (Fetal haemoglobin 3.8 g/dL, haematocrit 11.5%). Fetus received three intrauterine transfusions. Mother's initial haemoglobin was 10.4 g/ dL with anaemic picture. She was started on parenteral iron and erythropoietin therapy well-before delivery. Caesarean section was done with minimal blood loss at 32 weeks of gestation yielding a baby boy with a 1.44 kg birthweight and haemoglobin of 11.0 g/ dL. Newborn received short course of phototherapy and blood film revealed no features of haemolysis. Baby received 30 mL maternal blood transfusion and raised the haemoglobin up to 17.0 g/dL. Mother and baby were discharged 2 weeks later in a good condition. Discussion Management of this patient created a double challenge because we had to get blood for intrauterine transfusion from the anaemic mother. As maternal blood was the only option for fetal transfusion, optimisation of maternal haemoglobin, treatment for severe fetal anaemia and planning of delivery were the main barriers. Low maternal haemoglobin level itself is a risk factor for postpartum haemorrhage. Considering potential transfusion needs, maternal blood was preserved for pre-deposit autologous transfusion after improving her iron stores. We were also ready with least compatible blood and intravenous immunoglobulins to be used in an obstetric haemorrhage. This is the first case report in literature regarding Jk3 antibodies in pregnancy with severe fetal anaemia and ended up with a successful outcome for both mother and baby.
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Diagnosis of pulmonary embolism in pregnancy (DiPEP) Nelson-Piercy, C Women's Health Academic Centre, King's Health Partners, London, UK We will estimate the diagnostic accuracy, effectiveness and costeffectiveness of strategies (including clinical prediction rules) for selecting pregnant or postpartum women with suspected pulmonary embolism (PE) for imaging, and determine the feasibility and value of information of further prospective research. The study is funded by the National Institute for Health Research, Health Technology Assessment. DiPEP is a multicentre, case-control study of pregnant and postpartum women requiring diagnostic imaging for suspected PE and women with confirmed PE identified via the UK Obstetric Surveillance System (UKOSS). A clinical decision rule optimising sensitivity will be developed using recursive partitioning to identify the optimum combination of predictor variables. The evaluative potential of biomarkers, including d-dimers, will be explored. Decision-analysis modelling will estimate costs incurred and expected outcomes related to thromboembolism, bleeding and radiation exposure for a hypothetical cohort of women who receive no imaging, imaging for all, or a range of imaging strategies. Ethical approval obtained for the study was obtained from London Brent Research Ethics Committee. Recruitment opened in February 2015 and will close on target in September 2016. To date, 319 women with suspected PE have been recruited (target 325). UKOSS has identified 267 potential cases of a diagnosed PE, before case validation procedures. Analysis will be completed by March 2017 and full results available for presentation. The DiPEP study will report the largest and most comprehensive study to date of diagnostic methods to select pregnant or postpartum women with suspected PE for imaging.
JP213
Acute fatty liver of pregnancy complicated by haemoperitoneum Loh, M; Kathirvel, R KK Women's and Children's Hospital, Singapore, Singapore
Background We report a case of postpartum onset of acute fatty liver of pregnancy (AFLP) complicated by hepatic dysfunction with coagulopathy, microangiopathic haemolytic anaemia and haemoperitoneum. Case A 25-year-old woman with an uneventful antenatal period had a normal vaginal delivery at 39 weeks and 4 days of gestation in her second pregnancy. Her first pregnancy was complicated by preterm premature rupture of membranes at 28 weeks of gestation followed by preterm vaginal delivery. She did not have any significant past medical or surgical history. One hour after delivery, she complained of sudden onset epigastric pain. Her blood pressure was 177/106 mmHg. Her investigations revealed 3 + albumin on urine dipstick analysis, low haemoglobin of 8.5 g/dL and raised urine protein creatinine ratio, serum uric acid, total bilirubin, alanine transaminase and aspartate transaminase levels. Serum creatinine, platelets and coagulation profile were normal. A provisional diagnosis of preeclampsia/HELLP (haemolysis, elevated liver enzymes and low platelet count) was made. However, in view of her deteriorating clinical condition, worsening liver function tests and ultrasound abdomen suggesting moderate ascites, an alternative diagnosis of AFLP with coagulopathy was considered. A computed tomography of the abdomen and pelvis revealed a subcapsular haematoma, large amount of ascites and bilateral pleural effusion. Her liver function deteriorated further leading to disseminated intravascular coagulation. She received 2 units of fresh frozen plasma, 1 unit of cryosupernatant, 10 units of cryoprecipitate and 5 units of packed red blood cells. She was subsequently transferred to a tertiary general hospital for further supportive management. She made steady progress and was discharged on the 14th postnatal day in a stable condition. Conclusion AFLP is one of the rare but potentially dangerous liver conditions that occur in the third trimester of pregnancy and in the postpartum period. It can mimic other liver conditions such as pre-eclampsia, hepatitis and intrahepatic cholestasis of pregnancy. It is a multisystem disorder that could lead to complications including acute renal failure, coagulopathy, gastrointestinal bleeding, pancreatitis and encephalopathy. An accurate diagnosis of AFLP remains a major challenge even today. Diagnosis can be made through thorough history taking, physical examination and investigations, albeit with difficulty. Prompt recognition, supportive treatment and early fetal delivery remain the cornerstone in management. Although reaching the diagnosis of AFLP was challenging in this case, due to prompt recognition and treatment, she had a good outcome. Funding Nil.
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Red flags for dengue-related maternal mortality: lessons from the Malaysian confidential enquiries into maternal deaths Ganeshan, M 1 ; Krishnan, M 2 ; Jeganathan, R 3 ; Jaafar, S Introduction Approximately 2.5 billion people live in areas where dengue virus is endemic and Malaysia is among the endemic countries. There has been a global rise in dengue infections and an estimated 50 million people are infected annually. It is a significant cause of mortality, including among pregnant women; especially in endemic countries. The objective of this study is to analyse the dengue-related mortalities among pregnant women in Malaysia and to identify possible red flags for severe dengue in pregnancy. Methods This is a retrospective cohort study based on the confidential enquiries into maternal deaths in Malaysia, which is an established database of maternal deaths in Malaysia. The study period was between 2009-2013 and a total of 15 patients had serologically confirmed dengue-related mortality in pregnancy. All patients were included and specific variables were extracted for analysis. Results Despite being highly endemic in Malaysia and most patients presenting with fever, the suspicion of dengue was only established 46% of the time at initial presentation. Despite warning signs, the average duration to establish the diagnosis was 2 days. Fifty-three percent of the mortalities occurred in the third trimester and two-thirds had no underlying co-morbidities. Significant red flags of dengue-related mortality are fever (100%), body aches and abdominal pain (53%), nausea and vomiting (47%) and diarrhoea (47%). Rash (13%) was not a significant sign; 60% had tachycardia while only 13% had petechiae. The average duration of symptoms before admission was 3 days. Despite the classical association of thrombocytopenia and leucopenia, 73% of patients had platelet count >100 9 10 9 and 80% had no leucopenia during initial presentation. Haematocrit was >35% in 62%. Only 7% had haematocrit >40% which is currently the criteria for admission. One patient had spontaneous sub rectus haematoma with a platelet count of 25 9 10 9 and the risk of fetal loss following severe dengue was 67%. Conclusion Dengue is endemic in Malaysia and there needs to be a high index of suspicion in any patient presenting with warning signs without over reliance on time-consuming investigations. Fever, nausea, vomiting, diarrhoea and abdominal pain are significant red flags of severe dengue. The current criteria of assessment and intervention based on thrombocytopenia, haematocrits and leucopenia needs to be revised taking into consideration the physiological changes in pregnancy. The risk of fetal loss in severe dengue is significant.
JP215
Daily weight monitoring in pregnancy-a randomised controlled trial Arthur, C Introduction Excessive gestational weight gain (GWG) is associated with risks to both mother and offspring. Frequent weight monitoring helps to maintain weight and attenuates weight gain in those under short-term stressors associated with weight gain. This trial attempts to further clarify the relationship between GWG and pregnancy outcomes and investigates whether a resource-light intervention can help prevent excessive GWG. Methods Four hundred women were randomised to either standardised routine antenatal advice regarding exercise, diet and weight gain, or to receive a weight diary, scales and instruction to weigh themselves daily, in addition to routine advice. Data regarding weight changes in pregnancy, labour and pregnancy outcomes were collected and analysed with EXCEL and SPSS. Results The randomised groups were demographically similar. Birth outcome data were available for 384 women, with complete data available for 329 women. Women allocated to the intervention were statistically no more likely to develop gestational diabetes or hypertensive disorders during their pregnancy. There was no statistical difference in weight gain during the study period. Offspring growth parameters and resuscitative requirements were also similar between the two groups. Conclusion GWG was less in the experimental group, however this difference did not reach statistical significance. There were no adverse outcomes, either maternal or fetal, associated with this intervention. The most effective GWG attenuation programmes are multidisciplinary.
2-4 Daily weight measurement may play a role in helping pregnant patients adhere to weight gain recommendations, but is ineffective as a stand-alone weight management strategy. were measured by enzyme-linked immunosorbent assay and GFR was estimated using the Cockcroft-Gault equation. Main outcome measures Differences between prostacyclin and thromboxane A2 metabolites, prostacyclin-to-thromboxane ratio and GFR between groups. Results Women with HbSS had significantly lower serum 6keto-PGF1a concentrations than HbAA women, whether pregnant or nonpregnant (P < 0.001; P < 0.004, respectively). Conversely, pregnant HbSS women had significantly higher serum TxB2 (P < 0.001); non-pregnant HbSS women had non-significantly higher TxB2 concentrations. The 6keto-PGF1a:TxB2 ratio was markedly increased (pro-vasodilatory) in HbAA pregnancy (P < 0.001) but reduced in HbSS pregnancy (P = 0.037). GFRs (mL/minutes) were significantly higher in nonpregnant HbSS than HbAA (P < 0.008) but they were only marginally raised in HbSS women in late pregnancy (P = 0.019) while GFR rose markedly in HbAA women (P < 0.001). Conclusion The lower ratio of prostacyclin-thromboxane metabolites in HbSS pregnancy may indicate endothelial damage and an increased tendency to vasoconstriction and clotting. Interventions to increase prostacyclin and reduce thromboxane, such as low-dose aspirin, may be useful in their management. Introduction The objective was to study the association of umbilical artery Doppler velocimetry with histological changes of the placentas in gestational proteinuric hypertension (preeclampsia). Methods This was an observational comparative study, conducted at two tertiary care centres in Sri Lanka. A total of 50 placentas were studied. Twenty from patients with gestational proteinuric hypertension plus abnormal umbilical artery Doppler velocimetry and 20 from gestational age-matched patients with proteinuric hypertension plus normal umbilical artery Doppler velocimetry. A sample of ten placentas was taken from normotensive, uncomplicated pregnancies. Ultrasound scan for umbilical artery Doppler was carried out to obtain the pulsatility index (PI) and resistance index (RI) in consented mothers 24 hours before delivery. PI and RI values were categorised as abnormal If they were above the 95th centile for gestational age. Three randomly selected, haematoxylin & eosin-stained sections from the maternal surface of each placenta were examined under high power (magnification 940) of light microscopy. One hundred terminal villi in each slide were examined to identify the presence of syncytial knots, proliferative villous cytotrophoblast cells, thickening of subtrophoblastic basement membrane, and villous hypovascularity. Statistical analysis was carried out to compare the histological features between normotensive and hypertensive placentas. Within the hypertensive group, the histological features were further analysed in relation to umbilical artery Doppler velocimetry. Results The number of villi with syncytial knots, cytotrophoblast proliferation, thickened subtrophoblastic basement membrane, and villous hypovascularity was significantly higher in hypertensive placentas (all features: P < 0.00) compared with normotensive placentas. The histological features of hypertensive placentas were not influenced by maternal age or parity but a statistically significant increase in all histological features was noted with advancing gestational age in hypertensive pregnancies (>34 weeks of gestation compared with <34 weeks). The presence of all four histological characteristics were comparatively higher in the hypertensive placentas with abnormal umbilical artery Doppler velocimetry compared with normal Doppler velocimetry. But statistical significance was observed only in villous cytotrophoblast proliferation (P = 0.005), and villous hypovascularity (P = 0.002). Conclusion The placental histological changes; syncytial knots, villous cytotrophoblast proliferation, thickened subtrophoblastic basement membrane, and hypovascular villi are significantly increased in gestational proteinuric hypertension compared with normotensive pregnancy. Further deterioration of placental histology in gestational proteinuric hypertension was associated with the development of abnormal umbilical artery Doppler velocimetry.
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JP218
JP219
Severe early-onset intrahepatic cholestasis of pregnancy-management dilemmas Kotlinska, M; Hingorani, J Hull and East Yorkshire Hospitals, NHS Trust, Hull, UK Introduction Intrahepatic cholestasis of pregnancy (ICP) is a disorder of defective bile acid transport that results in systemic accumulation of bile acids, and typically presents with intense pruritus. It adversely affects maternal wellbeing and fetal outcomes. Commonly it occurs in the third trimester with about 80% of cases presenting after 30 weeks of gestation. However, it may develop as early as first trimester with just a few case reports in the literature. Methods We present a case of severe ICP that was diagnosed in early second trimester, did not respond to treatment with ursodeoxycholic acid (UDCA) and in consequence required delivery before 34 weeks of gestation. Results A 20-year-old nulliparous Caucasian woman was investigated with liver function tests and bile acids due to severe pruritus that started at 12 weeks of gestation. There were no signs of dermatological condition or jaundice on clinical examination. The only remarkable past medical history was intestinal lymphangiectasia and malabsorption in childhood. At 18 weeks of gestation bile acids were 88 lmol/L with unremarkable liver function tests. The ultrasound scan of the liver was normal and so was the hepatitis screen. Patient was started on UDCA, topical emollients, antihistamines and given a course of vitamin K. Despite the treatment, the bile acids continued to rise reaching maximum level of 211 lmol/L. Subsequently, she was tried on rifampicin 150 mg twice daily with some effect. The treatment was temporarily stopped, due to fetal dysrhythmia. Considering that raised levels of bile acids are arrhythmogenic and likely cause of fetal ectopic beats the rifampicin was restarted. Despite the drop in bile acids to 123 lmol/L the patient's symptoms continued to be severe and significantly affected her mental state. Fetal surveillance (ultrasound scan, cardiotocogram) remained normal, but in view of the debilitating symptoms the patient underwent elective caesarean section at 32+ weeks. Conclusion Typical treatment for ICP consists of topical emollients, antihistamines, UDCA and possibly vitamin K. Cholestyramine that has been used by some authors as indicated by the literature, has not been subjected to randomised trials and is not in clinical use, as suggested by RCOG. Rifampicin is not licensed for treatment for ICP but it has been used with very good results in other liver pathologies, including gallstones and primary biliary cirrhosis. In these cases, treatment with rifampicin resulted in significant decrease in serum levels of transaminases and total bile acids, as well as an improvement in pruritus.
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Advance maternal age: population study of obstetrical outcomes and morbidity Laws, P 1 ; Chuah, SC Introduction The objective was to determine the obstetric outcomes for women giving birth over the age of 40. Methods Retrospective study looking at the outcomes of 374 births of women 40 years of age and older (advanced maternal age; AMA) during a 10-year period at Maitland regional referral hospital, NSW, Australia. These were compared to a control group of 8769 births of 20-to 30-year-olds in the same time period. Inclusion criteria included singleton pregnancies and gestations over 34 weeks. Outcome measures included rates of caesarean section, operative delivery, stillbirth rates and maternal medical diseases including diabetes and pre-eclampsia. A subgroup analysis looking at comparison of primiparous woman of AMA and 20-to 30-year-olds was also performed. Results The AMA group had a higher stillbirth rate compared with the control group with odds ratio (OR) of 1.89, 95% confidence interval (95% CI) 0.40-7.9, P = 0.381. This showed an upward trend that was not statistically significant. The AMA caesarean section rate was 37.5% compared with 24.5% for control (OR 1.86, 95% CI 1.5-2.31; P = 0.000). There was no significant difference in the rate of instrumental deliveries (OR 1.17, 95% CI 0.82-1.65; P = 0.383). There was a small increase in late preterm birth rates (34-36.6 weeks) (OR 1.44, 95% CI 0.98-2.1; P = 0.059). There is a statistically significant increase risk of gestational diabetes mellitus (OR 4.41, 95% CI 3.38-5.76; P = 0.000) and chronic hypertension (OR 6.28, 95% CI 3.52-11.18; P = 0.000). There was a small but significant increase in rates of gestational hypertension (OR 1.49, 95% CI 1.00-2.24, P = 0.049) however there were fewer pre-eclampsia (OR 0.39, 95% CI 0.12-1.22; P = 0.093). A sub group analysis of primiparous woman showed that AMA compared with control was associated with higher rates of operative birth both instrumental and caesarean sections (instrumental OR 2.14, 95% CI 1.11-4.09; P = 0.019, caesarean section OR 2.4, 95% CI 1.33-4.33; P = 0.002).
Conclusion With the increasing use of in vitro fertilisation, and social acceptance in delaying falling pregnant, mothers of AMA are becoming more common place. Our study shows that AMA mothers have significantly increased risk for caesarean section. The risk for both caesarean and instrumental delivery increased with AMA primiparous women. The chance of having a coexisting medical disease such as chronic hypertension was significantly higher as well as higher rates of gestational diabetes. Mothers of AMA had decreased chance of pre-eclampsia. Maternity providers should be aware of these risks and the women should be counselled and followed-up appropriately.
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Epidemiology of pregnancy-associated cerebral venous sinus thrombosis in three referral hospitals in Khartoum, Sudan Hummeida, M; Azim Ali, A Alneelain University, Khartoum, Khartoum state, Sudan
Introduction Pregnancy induces several changes in the coagulation system, which persists into the puerperium resulting in a pro-thrombotic state. Cerebral venous thrombosis (CVST), has variable clinical presentations that can easily be misinterpreted with other neurological and obstetrical conditions such as eclampsia and epilepsy. Methods This is a case-control hospital-based study conducted from 1 January 2011 to 31 December 2012 to investigate the epidemiology of CVST during pregnancy and puerperium in three main referral hospitals in Khartoum, Sudan. The different variables were compared between women with confirmed CVST and two consecutive women who delivered in the hospitals without CVST using logistic regression analysis.
Results During the study period there were 31 patients with radiologically confirmed CVST. These hospitals had 37 471 deliveries annually, yielding an incidence rate of 0.01 per 100 000 deliveries. Among these 31 patients, 25 (80.6%) and 6 (19.4%) were identified during the postnatal and antenatal periods, respectively. The most common presenting symptoms were headache (77.4%) followed by convulsions (74.2%), neck pain (39%), neck stiffness (32.2%), limb weakness (29%), loss of consciousness (29%), impaired vision (25.8%), and cranial nerve symptoms (22.5%). Some patients may have more than symptoms. Initially, 25.8% of patients were misdiagnosed and mistreated as cases of eclampsia. Concerning risk factors, there was significant association between age (95% CI 1.0-1.2, OR 1.1, P = 0.024), mode of delivery (95% CI 3.8-58, OR 14.9, P = 0.000), anaemia (95% CI 1.0-26.1, OR 5.2, P = 0.041) and pre-eclampsia (95% CI 1.1-89.5, OR= 10, P = 0.039) with favourable outcome of CVST cases during pregnancy and puerperium. Conclusion CVST presenting with extremely varied symptoms can simply be mistaken for eclampsia, epilepsy and other neurological diseases. Caesarean delivery, older age, anaemia and pre-eclampsia are the dominant risk factors for pregnancy-associated CVST.
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Retrospective study on anaemia in pregnancy: effect on fetal and labour outcomes The objectives were to describe the prevalence of anaemia at booking visit and third trimester and to evaluate the effect of anaemia on fetal and labour outcomes. Methods This was a retrospective study carried out at North Colombo Teaching Hospital, Ragama, using North Colombo Obstetric Database (NORCOD) between March 2014 and August 2016. A total of 3449 women were included. Women with comorbidities and incomplete data were excluded from analysis. Anaemia was defined as haemoglobin (Hb) <11 g/dL in first trimester and <10.5 g/dL in third trimester. Babies with a birthweight <2500 g were considered low birthweight (LBW) while babies with a birthweight >3500 g were considered high birthweight (HBW) babies. Normal range for birthweight (NBW) was 2500-3500 g. Results Seven hundred and ninety-nine (23.2%) were anaemic during their booking visit while 308 (8.9%) had an Hb > 13 mg/ dL. Following routine iron supplementation during pregnancy prevalence of anaemia during third trimester was 9.7% (n = 334) and 21.4% (n = 737) had high Hb levels (>13 g/dL). Prevalence of LBW was 13.2% (n = 454) while 12.5% (n = 431) had HBW. LBW, NBW and HBW rates of babies delivered by anaemic women during the third trimester were 15.3% (n = 51), 71.3% (n = 238) and 13.5% (n = 45), respectively. Corresponding values of non-anaemic women were 12.9% (n = 403), 74.7% (n = 2326) and 12.4% (n = 386). This was not statistically significant. Two babies (0.6%) delivered by anaemic women had a 5-minute Apgar <7 while 30 (1.0%) babies of non-anaemic women had 5-minute Apgar <7 (P = 0.7). Caesarean section rate among anaemic women was 27.8% (n = 93) while non-anaemic women had a caesarean rate of 32.8% (n = 1022) with RR 0.9, 95% CI 0.7-1.0, P = 0.07. Conclusion Anaemic women showed a higher prevalence of LBW babies compared with non-anaemic women. However, the observed difference between the two groups was not significant.
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HIV-associated obstetric complications-examining the effect of highly active antiretroviral therapy Sebitloane, H; Moodley, J
University of KwaZulu Natal, Durban, South Africa
Introduction HIV is the leading cause of maternal deaths in resource-poor countries. The use of highly active antiretroviral therapy (HAART) has been shown to almost eliminate vertical transmission, as well as improve general maternal health outcomes. Its effect on direct obstetric conditions has not been well documented. Methods We conducted a retrospective audit of records of women who delivered at a regional hospital in the period April 2011 to April 2014. We employed a stratified random selection, where the first 50 files for each calendar month were chosen, at a ratio of one HIV uninfected for every four infected women. Results We analysed 1461 files, made up of 302 HIV-uninfected, and 1159 HIV-infected. HIV-infected women were further analysed according to the use of HAART, namely, those who used zidovudine, n = 424; those who initiated HAART prepregnancy, n = 312; and those who initiated in-pregnancy HAART, n = 423. We found that the use of prepregnancy HAART reduced the risk of anaemia and postpartum complications compared with women not receiving HAART. The women receiving HAART had an increased risk of preterm births (P = 0.004) and poor perinatal outcomes (P = 0.002). In addition there was a trend towards an increased risk of pre-eclampsia (P = 0.064). Conclusion The initiation of HAART before pregnancy and its continuation throughout pregnancy reduces the prevalence of anaemia and the frequency of postpartum complications. However, compared with HIV-positive pregnant women who did not receive HAART, HAART before pregnancy results in poor perinatal outcomes and may also increase the risk of preeclampsia. Introduction Glucose is actively transported across the placenta in an ATP-dependent process in which the fetus determines how much sugar it receives. It is only when the maternal glucose is persistently >10 that glucose crosses passively down the gradient into the fetus, leading to the fetus becoming hyperglycaemic. Fetal polyuria, on the other hand, as a consequence of gestational diabetes (GDM) has no mechanism unless the mother has uncontrolled diabetes. Polyhydramnios is defined as an amniotic fluid index (AFI) ≥ 24.9 (95th centile) or the deepest maximal vertical pocket (DVP) ≥ 8. There is a link with a two-to five-fold increase in the risk of perinatal mortality (4% fetal loss which increases to 60% if there are concurrent structural abnormalities). Maternal risks include placental abruption, preterm labour and postpartum haemorrhage. The reference standard diagnostic test for gestational diabetes is the 75-g oral glucose tolerance test (OGTT) conducted at 24-28 weeks of gestation.
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The objectives were to determine whether polyhydramnios is an independent risk factor for gestational diabetes, and if so how strong is the association? On how many occasions were women diagnosed with GDM, having previously had a normal OGTT earlier in pregnancy? Methods This multicentre audit identified cases of third-trimester polyhydramnios over a 2-year period 2014-2015. Cases were extracted from ViewPoint TM database, for singleton pregnancies with a DVP ≥ 8 in addition to an AFI ≥ 25. The results of respective tests for GDM were examined and compared (either a third-trimester OGTT or third-trimester capillary blood glucose monitoring). Patients were excluded with pre-existing diabetes, multiple pregnancies or fetal abnormalities. Results The range in number of cases of true 'idiopathic' polyhydramnios alone ranged from 40 to 70 in each unit. Polyhydramnios as an independent risk factor identified GDM in an average of 9% of cases. Of interest, a raised body mass index >30 kg/m 2 was only associated with these patients in around 50%
of cases and there were rarely signs of fetal macrosomia associated with polyhydramnios. Conclusion Based on this figure, the group supports continued testing for gestational diabetes in cases of isolated polyhydramnios. This audit group has compiled a flow-chart for the management of idiopathic polyhydramnios in pregnancy picked up in the third trimester. In the future, further research would include examining 'gestation-appropriate' AFI values and how these may guide clinical management as well as maternal and fetal outcomes for these patients.
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Successful pregnancy in a patient with univentricular heart and pulmonary stenosis Rajendraseelan, T 1 ; Gihan, C Background Cardiac disease in pregnancy carries considerable risk for both mother and fetus, thereby posing a great challenge to the obstetrician. Univentricular heart accounts for 3.2% of congenital cardiac abnormalities. Successful pregnancy associated with this condition is rare and it becomes a significant clinical dilemma between continuation and termination of pregnancy. Case A 22-year-old diagnosed patient with univentricular heart and pulmonary stenosis was referred to the tertiary care centre for medical termination of unplanned pregnancy at 24 weeks of gestation. She was diagnosed at the age of 12 years and aortopulmonary shunt has been created. Corrective cardiac surgery has been offered but she has defaulted. She belonged to risk class IV according to Modified WHO classification. At the time of presentation she was in NYHA class II and was plethoric and cyanosed. Oxygen saturation was 78% on room air. The multidisciplinary team decision was to continue the pregnancy with close monitoring till 28 weeks of gestation. At 28 weeks as her cardiac functions remained stable it was decided to continue the pregnancy until 32 weeks of gestation. She developed severe pre-eclampsia at 32 weeks of gestation and emergency caesarean section was performed. Live baby boy of 1240 g was delivered and managed at the special care baby unit. Patient received postoperative care in the intensive care unit. On the 6th postoperative day her level of consciousness dropped with evidence of upper motor neuron lesion. Computed tomography scan showed bilateral multiple infarctions involving bilateral cortex and cerebellum and most likely due to multiple emboli despite her treatment with thromboprophylaxis (lowmolecular-weight heparin and thrombo-embolic deterrent stockings). Two-dimensional echocardiogram and Duplex scan of lower limbs found to be normal. She was treated with warfarin and given specialised care at the stroke unit. She recovered fully without any residual damage. Conclusion Termination of pregnancy in the second trimester carries a similar risk to continuation of the pregnancy till the 28th week in patients with modified WHO class IV cardiac disease. It is a reasonable option to continue the pregnancy till fetal viability with close maternal and fetal monitoring. Further well-organised experienced multidisciplinary team input throughout the pregnancy and delivery at a specialised centre may improve maternal and fetal outcomes. Due to very high risk of thrombosis in these cases, careful consideration should be given for therapeutic doses of anticoagulation during the immediate postpartum period.
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Management outcome of cardiomyopathy in pregnancy-a Sri Lankan experience Fahim, M 1 ; Jayasundara, C 2 ; Gihan, C 2 ; Bandara, Cardiomyopathy in pregnancy is a rare acquired condition with a poor maternal and fetal outcome. The outcome of pregnancies affected by cardiomyopathy depends on well-organised multidisciplinary team work. The objective of this case series was to assess the management outcomes of cardiomyopathy in pregnancy at the main centre for management of cardiac conditions in Sri Lanka. A retrospective study of 19 consecutive pregnant women with cardiomyopathy including peripartum cardiomyopathy (PCM) managed at De Soysa Hospital for Women, Sri Lanka for a period of 5 years from 2012 to 2016. The data were gathered on a data entry form and statistical analysis was done using SPSS v20.
There were 19 women presenting with cardiomyopathy during this period with median age of 33 years. Out of them 78% were >30 years and 36.8% were >35 years. The median gestations were two with five primi-gravidae. PCM occurred in eight women (42.1%). The others were four dilated cardiomyopathy women and seven hypertrophic cardiomyopathy. Six PCM patients were diagnosed during the index pregnancy, two during previous pregnancies with recurrence. The median ejection fraction (EF) of PCM was 40%, hypertrophic 60% and dilated 50%. Ten (52.63%) had an EF more than 55%, eight (42.10%) <45%. Two patients had mild pulmonary hypertension. Three (16.6%) women developed gestational hypertension; another had chronic hypertension. Mitral valve regurgitation occurred in nine women while aortic regurgitation in one and mixed in two women. Three women had arrhythmias. One postpartum maternal death occurred due to severe decompensated PCM. Fetal growth restriction occurred in three mothers with one having chronic hypertension. All others had adequate fetal growth. All the women received multidisciplinary intensive unit or high dependency unit care. Mean hospital stay was 12.16 days (SD 5.862). Mean duration in intensive care unit was 3.58 (SD 1.98) days. Of the pregnancy outcomes two were terminated due to severe decompensation. Seventeen (89.4%) women had live births of which 14 (82.4%) were term and three (17.6%) were preterm. Nine (52.9%) had caesarean delivery and eight had vaginal deliveries. All received epidural anaesthesia. Mean birthweight was 2.647 kg (SD0.518); four babies required Special Baby Care; with no perinatal deaths. Eight (42.1%) mothers underwent female sterilisation. Cardiomyopathy in pregnancy is a condition that, even in the best-equipped institutions, can result in poor maternal and fetal outcome. But with careful evaluation and multidisciplinary approach a favourable outcome can be obtained.
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Single-dose intravenous iron infusion versus red blood cell transfusion for the treatment of severe postpartum anaemia: a randomised controlled pilot study Holm, C 1 ; Thomsen, LL 2 ; Norgaard, A 3 ; Langhoff-
Introduction There are no randomised trials comparing intravenous iron to red blood cell transfusion for the treatment of severe postpartum anaemia. The objectives of this study were to evaluate the feasibility of randomising women with severe postpartum anaemia secondary to postpartum haemorrhage to red blood cell transfusion or intravenous iron, and to describe patient-reported outcomes, and haematological and iron parameters.
Methods Women with a postpartum haemorrhage exceeding 1000 mL and a haemoglobin (Hb) between 5.6 and 8.1 g/dL were randomised to 1500 mg of intravenous iron (n = 7) isomaltoside or red blood cell transfusion (n = 6). Participants completed the Multidimensional Fatigue Inventory and Edinburgh Postnatal Depression Scale, and blood samples were drawn at inclusion, daily during the first week and at weeks 3, 8 and 12.
Results We screened 162 women and included 13 (8%). There was no significant difference between groups in fatigue or depression scores. Red blood cell transfusion was associated with a higher Hb on day one, inhibition of reticulocytosis during the first week, and low iron levels. Intravenous iron was associated with increased reticulocytosis during the first week, repleted iron stores and a higher Hb in weeks 3-12.
Conclusion This pilot study shows that intravenous iron could be an attractive alternative to red blood cell transfusion in severe postpartum anaemia, and that a larger trial is needed and feasible.
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Developing a pre-eclampsia core outcome set. McManus, RJ Introduction The objectives were to develop a core outcome set for pre-eclampsia. Methods An international steering group including healthcare professionals, researchers and patients, guided the development of this core outcome set. Potential outcomes were identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes were entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers and patients were invited to participate. The modified Delphi method encouraged whole and stakeholder group convergence towards consensus 'core' outcomes. Consensus was defined a priori.
Results Four hundred and thirty-five participants, representing eight stakeholder groups, from 55 countries participated in the first round of the Delphi survey. Consensus was reached for 22 maternal outcomes: (1) maternal mortality; (2) eclampsia; (3) HELLP syndrome; (4) abruption; (5) stroke; (6) coma; (7) encephalopathy; (8) blindness; (9) myocardial infarction; (10) cardiac failure; (11) cardiac arrest; (12) coagulopathy; (13) thromboembolic disease; (14) respiratory failure; (15) respiratory arrest; (16) pulmonary oedema; (17) liver failure; (18) renal failure; (19) cardiopulmonary resuscitation; (20) ventilation; (21) dialysis; and (22) admission to high dependency unit or intensive care unit. Consensus was reached for nine offspring outcomes: (1) offspring mortality; (2) birth asphyxia; (3) gestational age at delivery; (4) seizures; (5) intraventricular haemorrhage; (6) retinopathy of prematurity; (7) respiratory failure; (8) cognitive impairment; and (9) motor impairment, including cerebral palsy. Conclusion Embedding a pre-eclampsia core outcome set within future trials, systematic reviews and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes.
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Correlation between HbA1c at the diagnosis of gestational diabetes and postpartum oral glucose tolerance values Ake-Uzoigwe, R; Arora, A; Zhang, D; Salafia, C; Fuks, A; Akinnawonu F,Sanusi, A Icahn School Of Medicine, Queens Hospital Center Program, Jamaica, Queens, USA Introduction The objectives were to determine the correlation between haemoglobin A1c (HbA1c) values at the diagnosis of gestational diabetes (GD) and subsequent postpartum oral glucose tolerance (POGT) results.
Methods Retrospective cohort study of GD patients, delivered at Queens Hospital Center, January 2013 to December 2015. All patients with a diagnosis of GD were included in the study. The correlation between HbA1c values of patients at diagnosis of GD and postpartum (POGT) results was determined. Data were analysed via Pearson correlation using STATA. Results In all, 514 patients met study inclusion criteria, 485 patients had HbA1c values at diagnosis of GD, and 178 patients had POGT; 173 patients had both HbA1c and POGT values and were included in analysis. HbA1c values range from 4.8 to 10.4% (mean 5.6 AE 0.69). POGT values ranged form 51 to 353 mg/dL (mean 110 AE 36.8). Pearson correlation coefficient between HbA1c and POGT results was r = 0.48, P < 0.001. Hence there is a positive linear relationship between HbA1c and POGT. Conclusion Our study showed that diagnosis of glucose impairment/overt diabetes mellitus postpartum is associated with HbA1c levels at the diagnosis of gestational diabetes antepartum. Moutquin, J-M 18 ; Study Group CHIPS Introduction Blood pressure (BP) level and variability are associated with adverse cardiovascular outcomes, particularly for younger age groups, and the outcome of stroke. We examined the relationship between pregnancy outcomes and both BP level and variability among participants in the CHIPS Trial (NCT01192412). Methods BP level was defined as mean systolic (sBP) and diastolic (dBP) between randomisation and delivery. Our primary definition of BP variability was the SD of the two highest and two lowest post-randomisation office visit BP values, measured at least a week apart. Relationships were explored between outcomes and each of BP level and variability for the major outcomes in CHIPS: perinatal loss or high-level neonatal care for >48 hours (primary outcome), birthweight <10th centile, serious maternal complications (secondary outcome), severe maternal hypertension, pre-eclampsia, and delivery at <34 or <37 weeks of gestation. The BP level-outcome relationship was explored by mixed effects regression, and BP variability by logistic regression adjusted for treatment group ('less tight' versus 'tight'), gestational age at randomisation (categorical), last BP, and centre (as a random effect). P < 0.05 was considered of statistical and potential clinical significance.
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Results Of the 987 women in CHIPS, 961 had at least one office visit (median 7, interquartile range 4-10). For each of 'less tight' (versus 'tight') control, BP was higher among women who had an adverse outcome (versus women who did not) for all but serious maternal complications of which there were few (n = 28): primary outcome (in both groups, P < 0.0001 for sBP and dBP); birthweight <10th centile (in 'less tight': P = 0.04 for sBP and P < 0.0001 for dBP; for 'tight': P = 0.27 for sBP and P = 0.002 for dBP); severe hypertension and pre-eclampsia (in both groups, P < 0.0001 for sBP and dBP). Higher dBP variability (but not sBP) was associated with fewer primary perinatal outcomes (P = 0.02), birthweight <10th centile (p < 0.05 for dBP), and delivery at <34 (P = 0.005) or <37 weeks of gestation (P = 0.02).
Higher sBP and dBP variability were associated with more severe hypertension (P < 0.001 for sBP and P = 0.008 for dBP) and preeclampsia (P = 0.009 for sBP and P = 0.01 for dBP). Conclusion Higher BP is a biomarker for adverse outcomes, even when target BP is low as in 'tight' control (target dBP 85 mmHg). BP variability has a significant complex relationship with outcomes, possibly related to an adaptive response from the fetoplacental unit. Our data suggest that when antihypertensive therapy is not achieving target BP values or BP is not stable, enhanced surveillance may be prudent.
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Pregnancy outcome in patients attending Groote Schuur Hospital with pregestational and gestational diabetes van Zyl, H; Levitt, N Groote Schuur Hospital, Cape Town, South Africa
Introduction Worldwide the incidence of diabetes mellitus (DM) has dramatically increased. It is well described that poorly controlled DM is associated with poor pregnancy outcomes. This study aims to describe the pregnancy outcomes of patients attending Groote Schuur Hospital with pre-gestational and gestational diabetes. Methods A retrospective audit was undertaken of all women with pre-gestational and gestational diabetes who attended Groote Schuur Hospital obstetric care, from 1 September 2010 to 31 August 2011. Routinely collected information at booking and during the rest of pregnancy was entered onto a data abstraction form. Patients diagnosed with gestational DM (GDM) were further subdivided into two groups: GDM and impaired glucose tolerance (IGT) depending on the oral glucose tolerance test (OGTT) values. Results A total of 724 diabetic pregnancies were managed; 35 women had type I diabetes mellitus (DM1), 194 had type II diabetes mellitus (DM2) and 495 had GDM. The median glycated haemoglobin (HbA1c) value at booking was highest for DM1, followed by DM2 and lastly GDM. Overall, 10.7% of women had pre-existing hypertension and 9.8% of women developed preeclampsia (PET). 70.5% of women with DM1 delivered before 38 weeks of gestation. In the DM2 group, the preterm delivery rate was 38.6%, 34.9% for GDM and 22.3% for IGT. The caesarean section rate exceeded 50% in all groups. The overall perinatal mortality rate was 2.5% (25/1000 births) for the study population, with DM1 and DM2 contributing most (6.4% and 4.2%). Congenital malformations were present in 18 pregnancies (2.4%) overall, but in 5.7% of patients with DM1 and 4.6% of DM2. Conclusion The audit demonstrated outcomes similar to firstworld countries, with major congenital malformations, unexplained stillbirths and PET accounting for the majority of perinatal deaths. Stricter control before pregnancy to achieve lower or normal HbA1c levels preconception, might be the only intervention where change is possible.
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Feto-maternal outcome of HIV-positive pregnant women on HAART in Gambia-case-control study Anyanwu, M; Anya, S; Offiong, R; Ekele, B
Edward Francis Small Teaching Hospital, Banjul, Gambia
Introduction HIV infection in pregnant women remains a huge public health concern globally. There are conflicting reports regarding the effects of HIV infection on pregnancy outcomes in the highly active antiretroviral therapy (HAART) for all patient era.
The objective was to compare pregnancy outcomes among HIVinfected and uninfected women in Edward Francis Small Teaching Hospital, Banjul, Gambia. Methods Pregnant women attending antenatal clinic at the hospital were prospectively recruited and followed-up. HIVpositive and -negative mothers were matched for age and parity. Recruitment occurred irrespective of gestational age. At the time of delivery, obstetric and neonatal characteristics were entered into the computer database. Mothers and their children were followed until 6 weeks postpartum. The data were analysed with EPI-INFO version 7.1.5. Chi-square test at significant level of 0.05 and confidence level of 95% were used to determine significance. Results A total of 166 mothers, 55 HIV-positive and 111 HIVnegative controls, were in the study. The age range was between 18 and 45 years and parity was 0 to 8. The measured adverse outcome includes; low birthweight (20% versus 5.2%, odds ratio [OR] 4.6, 95% confidence interval [95% CI] 1.46-14.2; P = 0.01220) and maternal anaemia (40% versus 11%, OR 5.4, 95% CI 2.3-12.6; P = 0.0001). Both showed statistical significant difference. Preterm delivery; 29.2% and 26.6% (OR 1.14, 95% CI 0.52-2.46; P = 0.9) and stillbirth, low Apgar score at 5 minutes and SBCU admission of 5.45% versus 0-0.9% showed no statistical difference (OR 6.3, 95% CI 0.6-6.25; P = 0.21). The absolute CD4 count of 350 cells/mm 3 and above (57.13%) was associated with low incidence of low birthweight. The mean glycaemic results were within normal range, 4.02-4.75 and 5.00-6.79 mmol/L pre-and post-prandial, respectively. Conclusion HIV infection could be an independent risk factor for low birthweight and maternal anaemia.
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Pregnancy management and outcomes in women of 40-years-old and over in a London hospital Novak, A; Black, B; Das, I; Mellon, C
The Whittington Health, London, UK Introduction In the UK there has been a significant increase in births in women over 40-years-old, from 1.2% in 1985 to 3.6% in 2008 with the average age of mothers now being 30.2 years. The fertility rate for women over 40 is now above the rate for women under 20. There are associated risks with increasing maternal age, including maternal co-morbidities and poor fetal outcomes. The objectives were to review all pregnancies in mothers over 39 years of age at a London Hospital over a 1-year period. Results to guide future protocols and management.
Methods All clinical notes of mothers over 39 years for the sample period were requested. Handwritten notes and electronic system records were reviewed; where vital information (e.g. birth record) was missing the patient was excluded. In all, 52 patient cases were reviewed. Data collected included demography, method of conception, maternal co-morbidities, mode of delivery and maternal/fetal outcomes, this was recorded with EXCEL.
Results The women's ages ranged from 40 to 48 years with a decreasing number of women as maternal age increased. Most women conceived spontaneously; however, at least 28% of women had in vitro fertilisation, of which at least 61% had a donor egg. Method of conception was not universally documented, if not stated it was assumed to be spontaneous. There were only two multiple pregnancies, both of which were delivered by caesarean section. The most common co-morbidity was gestational diabetes, followed by psychiatric conditions. There were 12 other comorbidities recorded. 29% of women had had previous uterine surgery (caesarean section and/or myomectomy); 35% of women had an elective caesarean section and 21% of women had induction of labour. The most common mode of delivery was caesarean section, the overall rate being 60%, which is higher than the hospital rate of, 31% were delivered vaginally, of which 10% were assisted. 20% of babies had a low birthweight, but only 20% of mothers received aspirin antenatally. Conclusion All women were delivered or induced by 40 weeks of gestation, which is in-keeping with UK national guidance. There was a high caesarean section rate for this group, though this is partially skewed by the high incidence of previous uterine surgery. Prescribing of aspirin was 20%, the guidance for this is unclear for this age group, however there was a high rate of low birthweight infants suggesting that may be of some benefit. Consecutive patients with all forms of cardiovascular disease, presenting during pregnancy or in the postpartum period, were enrolled into the database, with the aim of investigating maternal and fetal outcomes in this group. Over a 6-year period between the 1 July 2010 and 30 June 2016, 55 women with PH were included in this cohort. PH due to left heart disease (LHD-PH) was the most common form of PH and present in 42 patients (76%). The remaining 13 patients had pulmonary arterial hypertension (PAH), in these instances associated with congenital heart disease (CHD-PAH). Fifteen patients were primigravidas (27%) and 8 of these 15 women were not known with heart disease before pregnancy. The degree of PH was mild (right ventricular systolic pressure [RVSP] <50 mmHg) in 64% of patients (n = 35), moderate (RVSP 50-70 mmHg) in 31% (n = 17) and severe (RVSP >70 mmHg) in 5% (n = 3). Cardiac failure occurred in 28 patients (49%) during the pregnancy and there were two maternal deaths (4%) reported. The first maternal death occurred within the 42-day postpartum reporting period and the second death was a 'late' maternal death, having occurred 6 months post delivery. Caesarean section was performed in 27 patients (49%) and 15 of these 27 patients were symptomatic at the time of delivery. Only two patients agreed to a therapeutic termination of pregnancy. Fetal complications were miscarriage (n = 1), stillbirth (3.6%, n = 2), early neonatal death (3.6%, n = 2), preterm delivery before 34 weeks of gestation (7%, n = 4) and low birthweight of <2500 g (25%, n = 14). Most patients received diuretics (89%, n = 49) and five patients (9%) were managed with advanced pH therapy such as sildenafil during pregnancy. Conclusion Mortality, in this group of patients with pulmonary hypertension, was lower than previously reported as specialised care during pregnancy and delivery were available. However, maternal and fetal morbidity remains prohibitively high. Early advice on contraception, pregnancy risk and fetal outcome remains paramount.
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Zero weight gain in pregnancy and risksretrospective, observational study Reddy, P; Aziz, N Fernandez Hospital, Hyderabad, India
Introduction Weight gain during pregnancy has been shown to have immediate and late effects on health of a mother and baby. Lack of weight gain or decreasing maternal weight has not been evaluated as an entity and in clinical practice becomes a worrying factor for both the mother and care provider. We hypothesise that outcomes of pregnancy are much worse in this category and hope to quantify the outcomes. The aim was to study the maternal and fetal outcomes in mothers who had no weight gain in pregnancy and compare with normal weight gain in mothers with a normal body mass index (BMI ) with the Institute of Medicine's recommended weight gain in pregnancy (9-11 kg), excluding diabetes. Primary outcome was to study the incidence of zero or less weight change in pregnancy. Secondary outcomes included diagnosis of new problems in pregnancy, hospital/intensive care unit (ICU) admissions, severe maternal morbidity (CDC, ICD-9-CM) and maternal deaths. Fetal and neonatal variables included prematurity rates, small-forgestational-age (SGA), low Apgar, neonatal ICU admissions, stillbirth and neonatal deaths. Results Study included a total of 17 118 first-trimester booking mothers out of 36 663 deliveries. No weight gain in pregnancy, excluding diabetes and obese, were 76, an incidence of 1 in 225. Compared with the control group of 1683 singleton pregnancies, we found higher incidence of HIV (2.6% versus 0.4%, OR 5.64), chronic bowel diseases (2.6% versus 0.2%, OR 11.31) and recurrent pregnancy losses (6.5% versus 2.2%, OR 3.04). Diagnostic testing for weight loss detected tuberculosis (2.6% versus 0), scrub typhus in one and hyperthyroidism (9.2% versus 0.7%), which were statistically significant findings. Preterm births <34 weeks were higher 7.9% versus 2.6%, OR 3.7 (1.51-9.04). Severe acute morbidity was 3.39% versus 0.5%, OR 7.62 (2.02-28.7). Fetal outcomes were high SGA rates (21% versus 11.7%), stillbirths (6.5% versus 0.6%), lower mean birthweight with ten times higher perinatal mortality. Conclusion Weight loss or no weight gain in pregnancy should stimulate a work up for chronic disease, infections and surveillance for adverse outcomes.
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Fetus and a shrunken liver Mehta, A; Singh, V; Wright, A Royal Free Hospital, London, UK Background Pregnancy is a rare event in patients with cirrhosis. Very few pregnancies are documented with UKELD of 50 or more (United Kingdom Model for End-Stage Liver Disease or UKELD score). We present a 29-year-old lady from Liberia with a background history of Child's A Liver cirrhosis secondary to hepatitis B complicated by portal hypertension, grade 1-2 oesophageal varices and thrombocytopenia. She was on propranolol primary prophylaxis. She had no clinical ascites or encephalopathy. Case Preconceptionally she was advised against pregnancy as her UKELD score was 50. She was advised to have liver transplant before pregnancy but she conceived spontaneously before that. Her booking bloods were unremarkable except platelets of 65, AST 68, ALT 74 and INR of 1.6. She had a multidisciplinary input for her care with obstetricians, hepatologists, haematologists, anaesthetists and paediatricians. She was seen regularly in antenatal clinic with some appointments joint with Hepatology. Her liver functions remained stable during pregnancy and she continued tenofovir and propranolol. A repeat OGD in second trimester showed a grade 1 barely noticeable oesophageal varices. Her platelets dropped to a low of 29 around 35 weeks and remained between 30 and 55 throughout. The fetus developed intrauterine growth restriction. As the varices were minimal, overall risk of bleeding was small, hence vaginal delivery was an option but the challenge was thrombocytopenia as an emergency caesarean would be a risk so it was decided that the safest option would be an elective caesarean at 37 weeks of gestation with perioperative platelet transfusion. She came in spontaneous labour at 37 weeks of gestation, a day before caesarean section and proceeded to a very quick uncomplicated vaginal delivery without analgesia. A male baby was born in good condition with a total blood loss of 200 mL. Conclusion As the treatment of cirrhosis improves, pregnancy in patients with cirrhosis is likely to become more common. These women face unique risks in pregnancy. The risks in mother are of miscarriage 30-40%, variceal bleeding 10-78%, hepatic decompensation, splenic artery aneurysm rupture, hepatic encephalopathy, postpartum haemorrhage and maternal death (3.4% if UKELD is >47). The risks in fetus are of prematurity up to 25%, intrauterine growth restriction, stillbirth and risk of hepatitis infection. A good multidisciplinary input and planning is the key to successful management of these complex pregnancies. Over 300 000 women die from complications of pregnancy and childbirth every year; the vast majority in developing countries. Intramuscular (IM) oxytocin is the gold standard for prevention of postpartum haemorrhage, which accounts for 19.7% of maternal deaths, but access in developing countries, is limited by formulation instability and availability of professionals to administer injections. A heat-stable, inhaled (IH) form of oxytocin, delivering comparable systemic levels to the IM route could improve maternal mortality and morbidity. Safety, tolerability and pharmacokinetics (PK) of IH oxytocin and IM oxytocin were assessed in healthy nonpregnant volunteers. Methods This was a single-blind, dose-escalation, fixed-sequence study in healthy, premenopausal, non-pregnant, non-lactating women aged 18-45 years. In dosing session 1 (S1), subjects received IM oxytocin 10 IU on day 1, IH placebo on day 2 and IH oxytocin 50 lg on day 3. In dosing S2 to S4, subjects were randomised to receive either IH placebo or ascending doses of IH oxytocin (200, 400, 600 lg). Plasma PK profiles were compared for each IH dose versus IM oxytocin focusing on rate and extent of systemic exposure, specifically quantified concentration at 10 and 30 minutes (Cp10 and Cp30) post-dose and area under concentration-time curve over 3 hours post dose (AUC 0-3 h ). Adverse events (AEs), laboratory tests, vital signs, electrocardiograms, physical exams, telemetry and spirometry were assessed.
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Results Fifteen of 16 randomised women completed the study. The shape of the observed PK concentration-time profile following IH administration was consistent with the IM PK profile and median oxytocin plasma concentrations were comparable for 400 lg IH oxytocin and IM oxytocin 10 IU. Adjusted geometric mean ratios (aGMR; IH : IM) for PK parameters were >1.0 for Cp10, Cp30 and AUC 0-3 h following 400 and 600 lg IH oxytocin and <1 for the lower doses. The aGMR (90% CI) for PK parameters Cp10, Cp30 and AUC 0-3 h were 1.10 (0.85-1. Wegener's Granulomatosis (WG) is a rare form of multisystem disseminating necrotising vasculitis, thought to be the result of an autoimmune inflammatory granulomatous process affecting endothelial cells in small and medium sized vessels. Despite the impressive improvements in life expectancy relevant therapeutic protocols are limited. Diagnosis in women of reproductive age is extremely unusual with less than 20 cases of WG diagnosed for the first time during pregnancy worldwide. We present a case of a 25-year-old nulliparous woman who has been initially presented at 25/40 with persistent upper respiratory tract infection symptoms. The positive c-ANCA with anti-proteinase-3 titre of 23.4 ELISA units (normal range <1.5 units), raised a clinical suspicion of WG. She underwent a lung CT that revealed granulomata in the left upper zones and nasal biopsy ultimately demonstrated WG. This was a new diagnosis of WG affecting both her chest and her upper airway. She was immediately commenced on aggressive immunosuppressant therapy with high doses of steroids and azathioprine. She did respond well to treatment and maintained low TPMT levels throughout her relatively straightforward pregnancy following initiation of immunosuppressive regime. She had a spontaneous preterm labour and a normal vaginal delivery of a healthy baby girl at 36 weeks. No adverse fetal outcomes had occurred and she was subsequently discharged home on day 2 with follow-up in the outpatient clinic. Similar cases pose challenging treatment algorithms as there is small clinical experience and management protocols are often empirical. Lack of robust evidence-based guidelines highlights the importance of individualised multidisciplinary clinical decision-making in the optimum management of these complex pregnancies. With the potential life threatening consequences, prompt treatment of the disease in pregnancy should be adopted. Traditional therapeutic options have two main components: induction of remission with immunosuppressive therapy, and maintenance immunosuppressive therapy for a variable period to prevent relapse. Maintenance therapy during pregnancy is a combination of steroids and cyclophosphamide and remission is often sustained with the use of azathioprine. There are no controlled trials as to the safety of many drugs in pregnancy and the experience of WG in pregnancy comes from anecdotal case reports. Alternative therapeutic options include cyclosporine and intravenous immunoglobulin. In conclusion, WG in pregnancy is extremely rare but needs to be considered as a differential diagnosis in patients presenting with atypical otolaryngological and respiratory symptoms and raised inflammatory markers. Introduction Visual inspection with acetic acid is a low-cost screening tool with huge potential to reduce the cervical cancer rate in low-resource settings. In order to maximise its applicability in our environment however, there is need to validate it using a known screening reference standard (cervical cytology). The objectives were to determine the sensitivity and specificity of visual inspection with acetic acid using cytology as a gold standard. Also to determine the risk factors for squamous intraepithelial neoplasia in women with positive visual inspection with acetic acid and cytology. Results The sensitivity and specificity of visual inspection with acetic acid were 69% and 94%, whereas the negative and positive predictive values were 45% and 98%, respectively. Identified risk factors for squamous intraepithelial lesions include high parity, low education, low age at coitarche and delivery. Conclusion Visual inspection with acetic acid has moderate sensitivity and good specificity. The high negative predictive value shows that it could be a valuable triaging tool in cervical cancer screening.
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A rare case of primary carcinosarcoma arising from pouch of Douglas Wong, KY; Ng, AX; Mansor, S; Lim, TYK KK Women's and Children's Hospital, Singapore, Singapore Background Carcinosarcomas are aggressive tumours characterised by both epithelial (carcinomatous) and connective (sarcomatous) tissue elements, mostly arising from the uterus. Extragenital carcinosarcomas are rare and most cases develop in the pelvic peritoneum. We report a case of primary carcinosarcoma arising from the pouch of Douglas (POD). Case A 74-year-old woman with no co-morbidities presented with pelvic organ prolapse. An endometrial sampling was performed which revealed serous carcinoma. Subsequent imaging showed a large mass in the POD inseparable from the uterus with peritoneal deposits raising differentials of synchronous uterine and ovarian cancer or metastatic deposit from uterine cancer. She underwent
